Human targeted phenobarbital presents a poor substrate of gut microbiome deciphering new drug targets beyond pharmacokinetic curbs
Abstract Background The gut microbiome, a new organ of the body, can potentially alter the pharmacokinetics of orally administered drugs through microbial enzymes. However, absorption of orally administered non-antibiotic drugs by the gut microbiome, during drug-microbiome interaction, is barely add...
Saved in:
Main Authors: | Imran Mukhtar (Author), Haseeb Anwar (Author), Arslan Iftikhar (Author), Heba E. Hashem (Author), Qasim Ali (Author), Farhan Siddique (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sulpiride Serves, a Substrate for the Gut Microbiome
by: Imran Mukhtar, et al.
Published: (2021) -
The Competitive Absorption by the Gut Microbiome Suggests the First-Order Absorption Kinetics of Caffeine
by: Imran Mukhtar, et al.
Published: (2021) -
Diversity of Vaginal Microbiome in Pregnancy: Deciphering the Obscurity
by: Parakriti Gupta, et al.
Published: (2020) -
Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon
by: Hamid A. Bakshi, et al.
Published: (2021) -
Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
by: David A. Hart
Published: (2015)